European Parliament Urged to Take Action to End Wasteful Spending at CERN and Save Lives
Dallas, TX – On June 2, 2025, the Crosetto Foundation for the Reduction of Cancer Deaths issued an urgent call to Members of the European Parliament (MEPs) to intervene and prevent further waste of taxpayer funds at CERN, the European Organization for Nuclear Research. The foundation is requesting a public scientific meeting between the designers of CERN’s current 650 kW FPGA-Based Level-1 Trigger system and inventor Dario Crosetto, to compare it with his proven 3D-Flow architecture, which consumes only 6 kW and performs over 8,000 programmable operations at a fraction of the cost. The meeting aims to correct decades of inefficiencies in research spending and accelerate the adoption of technologies that save lives and reduce costs.
Inconsistencies at CERN have raised serious questions about the allocation of public resources and the need for transparency and accountability in taxpayer-funded research. Despite overwhelming and unchallenged scientific evidence, CERN has opted for less effective and more expensive Field Programmable Gate Array (FPGA)-based architectures for over three decades. This decision has not only resulted in multiple costly implementations that have failed to meet performance needs, but has also delayed the immense benefits of 3D-Flow in physics, medicine, and defense.
Italian-American scientist Dario Crosetto, inventor of the 3D-Flow architecture, has been recognized for its unparalleled efficiency in accurately recognizing objects (particles) traveling at the speed of light. His invention laid the groundwork for the 3D-CBS (3D-Complete Body Screening), an advanced PET/CT technology that enables early detection of many diseases, including cancer, with life-saving potential and reduced healthcare costs. This earned him the Leonardo da Vinci Prize in 2011 for the most efficient solution in particle detection for early cancer diagnosis.
Despite its proven capability, for over 30 years CERN has instead adopted FPGA-based architectures, which have failed to meet performance needs and delayed the 3D-Flow’s lifesaving and cost-saving benefits. Notably, no scientific institution—including the highly esteemed Pontifical Academy of Sciences, which counts 86 Nobel laureates among its past and present members—has been able to technically refute Crosetto’s findings. This has raised concerns about the fairness and openness of scientific evaluations.
The Crosetto Foundation urges the European Parliament to submit a ‘Parliamentary Question for Written Answer’ to the European Commission, requesting a public scientific meeting between CERN and Crosetto. The foundation believes that this critical step will compel the European Commission to investigate and potentially suspend funding for similar, less efficient FPGA-based projects, redirecting resources toward solutions that genuinely advance science and improve society’s well-being.
This issue is not just about high-energy physics; it is about protecting taxpayer funds, ensuring fairness and openness in scientific evaluations, accelerating the deployment of technologies that reduce cancer deaths, and defending the right of citizens to demand accountability. The current FPGA-Based Level-1 Trigger system cannot meet performance requirements through 2036, and without intervention, public money will continue to fund systems that consume more, do less, and slow scientific progress.
The Crosetto Foundation for the Reduction of Cancer Deaths, a U.S. 501(c)(3) nonprofit, is committed to saving lives through innovation and integrity in science. The foundation has been awarded the Gold Seal for Transparency for eight consecutive years from GuideStar. To support transparency and innovation, the Crosetto Foundation is accepting tax-deductible donations.
For more information, please visit https://www.guidestar.org/profile/03-0544575.
###
Derick is an experienced reporter having held multiple senior roles for large publishers across Europe. Specialist subjects include small business and financial emerging markets.